Novel Therapies in Hepatitis C Virus, An Issue of Clinics in Liver Disease, 1st Edition
Author :
By Paul J. Pockros, MD
The Guest Editor presents state-of-the-art articles devoted to therapies for treatment of HCV. The novel therapies addressed in this issue include interferons, viral kinetics and anti-viral resistence, anti-fibrotics, immunotherapeutics, hepatoprotec
...view more
The Guest Editor presents state-of-the-art articles devoted to therapies for treatment of HCV. The novel therapies addressed in this issue include interferons, viral kinetics and anti-viral resistence, anti-fibrotics, immunotherapeutics, hepatoprotectants and caspace inhibitors, and cyclosporine analogues, to name a few.
The Guest Editor presents state-of-the-art articles devoted to therapies for treatment of HCV. The novel therapies addressed in this issue include interferons, viral kinetics and anti-viral resistence, anti-fibrotics, immunotherapeutics, hepatoprotectants and caspace inhibitors, and cyclosporine analogues, to name a few.
Author Information
By Paul J. Pockros, MD, Scripps Research Institute, La Jolla, CA
https://www.asia.elsevierhealth.com/novel-therapies-in-hepatitis-c-virus-an-issue-of-clinics-in-liver-disease-9781437712360.html299579Novel Therapies in Hepatitis C Virus, An Issue of Clinics in Liver Diseasehttps://www.asia.elsevierhealth.com/media/catalog/product/https://www.asia.elsevierhealth.com/media/catalog/product/placeholder/default/generic_item_image_123x160_1_1.png89.0998.99USDInStock/Medicine & Surgery/Gastroenterology & Hepatology/Clinics/Medicine/Gastroenterology & Hepatology/Clinics/Clinics/Medicine/Gastroenterology & Hepatology/Japan Titles43351394388725505460750546665255041525989452631601418269243350884886536505455351451205259833The Guest Editor presents state-of-the-art articles devoted to therapies for treatment of HCV. The novel therapies addressed in this issue include interferons, viral kinetics and anti-viral resistence, anti-fibrotics, immunotherapeutics, hepatoprotectants and caspace inhibitors, and cyclosporine analogues, to name a few. The Guest Editor presents state-of-the-art articles devoted to therapies for treatment of HCV. The novel therapies addressed in this issue include interferons, viral kinetics and anti-viral resistence, anti-fibrotics, immunotherapeutics, hepatoprotectants and caspace inhibitors, and cyclosporine analogues, to name a few.00add-to-cart97814377123602011 and earlierProfessionalBy Paul J. Pockros, MD20091Book152w x 229h (6.00" x 9.00")Saunders0Aug 19, 2009IN STOCKBy <STRONG>Paul J. Pockros</STRONG>, MD, Scripps Research Institute, La Jolla, CAClinicsClinicsThe Clinics: Internal MedicineUnited StatesNoNoNoNoPlease SelectPlease SelectPlease Select
